AXMOX-T
COMPOSITION:- Moxifloxacin 0.5% w/v + Tobramycin 0.3% w/v + SOCOphthalmicSolution
PACKAGE:- 5ml
Devaksh Lifesciences has engineered AXMOXT as a premium dual-antibiotic solution to combat complex bacterial ocular infections. By combining a 4th generation fluoroquinolone (Moxifloxacin) with an aminoglycoside (Tobramycin), this formulation provides a “double-shield” mechanism. It covers a wide spectrum of pathogens, which will guarantee the elimination of even the resistant bacterial strains within a short time, preventing the further spread of an infection and shortening the duration of recovery.
Key Features:
- Broad spectrum dual-antibiotic synergistic formula.
- Prevents bacterial protein synthesis and growth of bacterial DNA.
- Highly effective against both Gram-positive and Gram-negative bacteria
- Better deep tissue invasion against deep-seated infection of the eye.
Benefits & Advantages:
- Lessens the chances of resistance of the bacteria.
- The rate of clinical cures is higher than that of single-antibiotic drops.
- Offers a holistic cure to persistent or chronic infections.
- Reduces the damage of the ocular surface through the quick resolution of infection.
Usage & Clinical Highlights:
- Intended to be used in those patients with severe bacterial keratitis or conjunctivitis.
- Recommended in the prevention of ophthalmic surgeries of high risk.
- Used as a choice in cases of infections that have not been responding to monotherapy.
- Clinically proven as being highly effective against Pseudomonas and MRSA.
- Well suited in the treatment of complex infections of the ocular surface.
